Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 6 of 6 for “"CD4 Down-Modulation"”.

  1. Synthesis and CD4 down-modulation potencies of CADA head analogs

    … cyclotriazadisulfonamide (CADA) is known to down-modulate expression of the transmembrane protein CD4 by blocking its co-translational translocation across the ER membrane. By this mechanism, CADA compounds prevent entry of HIV into host cells. Previous studies of solid-state conformations …

    unr Repository record for Synthesis and CD4 down-modulation potencies of CADA head analogs (opens in a new tab)

  2. Pyridine-fused Cyclotriazadisulfonamide (CADA) Compounds: Synthesis and CD4 Down-Modulation Potency

    … (CADA) is a small molecule that down-modulates expression of human CD4 (hCD4). The mechanism of action involves binding to the signal peptide (SP) of hCD4, locking it in the channel across the membrane of the endoplasmic reticulum (ER), preventing its translocation into the ER …

    unr Repository record for Pyridine-fused Cyclotriazadisulfonamide (CADA) Compounds: Synthesis and CD4 Down-Modulation Potency (opens in a new tab)

  3. Synthesis of Novel CADA Analog Prodrugs and Ring-Size Variants Designed to Act as anti-HIV Agents via Down-Modulation of the CD4 Receptor

    … (CADA) inhibits HIV replication by selectively down-modulating expression of the CD4 receptor protein on host cells. Current studies are aimed at developing a prodrug approach involving various CADA analog prodrug parent compounds bearing dipeptide chains that are covalently bonded to two amino …

    unr Repository record for Synthesis of Novel CADA Analog Prodrugs and Ring-Size Variants Designed to Act as anti-HIV Agents via Down-Modulation of the CD4 Receptor (opens in a new tab)

  4. Synthesis and Structure-Activity Relationship Studies of Cyclotriaza Compounds as CD4 Down-Modulators and Anti-HIV Agents

    … inhibits human immunodeficiency virus (HIV) by down-modulating cell surface CD4 receptor expression. More specifically, CADA inhibits co-translational translocation of nascent human CD4 across the endoplasmic reticulum (ER) membrane. The goal of the studies described here is to optimize the …

    unr Repository record for Synthesis and Structure-Activity Relationship Studies of Cyclotriaza Compounds as CD4 Down-Modulators and Anti-HIV Agents (opens in a new tab)

  5. Synthesis of Sulfonamides Towards Down-Modulation of CD4, gp160, and TSHR

    … of CADA to the signal peptide (SP) of human CD4 (hCD4) inside the membrane of the endoplasmic reticulum (ER), blocking the translocation of the protein into the ER lumen, and ultimately preventing the transport of the mature protein to the cell membrane. Through an alanine scan experiment, it …

    unr Repository record for Synthesis of Sulfonamides Towards Down-Modulation of CD4, gp160, and TSHR (opens in a new tab)

  6. Optimizing the Drug-Like Properties of CADA Compounds and Synthesis of Cyclic Peptides as Potential CD4 Down Modulators

    … immunodeficiency virus (SIV) by selectively down-modulating the expression of cell-surface CD4. More specifically, CADA inhibits co-translational translocation of nascent human CD4 across the endoplasmic reticulum (ER) membrane. Many CADA analogs have been synthesized and tested for CD4 …

    unr Repository record for Optimizing the Drug-Like Properties of CADA Compounds and Synthesis of Cyclic Peptides as Potential CD4 Down Modulators (opens in a new tab)